Assign the following ICD-10-PCS codes: 0WHG33Z Insertion of infusion device into peritoneal cavity, percutaneous approach, for the catheter insertion 0JH80WZ Insertion of reservoir into abdomen subcutaneous tissue and fascia, open approach, for insertion of the peritoneal port
Code | Description |
---|---|
96365 | INTRAVENOUS INFUSION, FOR THERAPY, PROPHYLAXIS, OR DIAGNOSIS (SPECIFY SUBSTANCE OR DRUG); INITIAL, UP TO 1 HOUR |
96366 | INTRAVENOUS INFUSION, FOR THERAPY, PROPHYLAXIS, OR DIAGNOSIS (SPECIFY SUBSTANCE OR DRUG); EACH ADDITIONAL HOUR (LIST SEPARATELY IN ADDITION TO CODE FOR PRIMARY PROCEDURE) |
HCPCS Code | Description |
---|---|
J1569a | Injection, immune globulin (GAMMAGARD LIQUID), intravenous, non-lyophilized (eg, liquid), 500 mg |
J1569JBb |
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
Title XVIII of the Social Security Act, §1833 (e) states that no payment shall be made to any provider for any claim which lacks the necessary information to process the claim. Title XVIII of the Social Security Act, §1842 (b) (18) (C) and (p) (1), describes payment for services that may be furnished by a practitioner.
The information in this article contains billing, coding or other guidelines that complement the Local Coverage Determination (LCD) for Intravenous Immunoglobulin (IVIG) L34580.
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
Title XVIII of the Social Security Act, Section 1833 (e) states that no payment shall be made to any provider of services or other person under this part unless there has been furnished such information as may be necessary in order to determine the amounts due such provider or other person under this part for the period with respect to which the amounts are being paid or for any prior period..
This Billing and Coding Article provides billing and coding guidance for Local Coverage Determination (LCD) L35093 (Intravenous Immune Globulin [IVIG]).
It is the provider’s responsibility to select codes carried out to the highest level of specificity and selected from the ICD-10-CM code book appropriate to the year in which the service is rendered for the claim (s) submitted. The following ICD-10 codes support medical necessity and provide coverage for HCPCS code J0850:
All those not listed under the “ICD-10 Codes that Support Medical Necessity” section of this article.
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
I won’t discuss every change, however, I will review major changes to the codes in the tables. Note that many body part and substance/technology additions were made to the index as well as the tables. There were 23 pages in the ICD-10-PCS Fy2022 Index update.
A new device for “T- Computer-aided Mechanical Aspiration” has been added to New technology section, Cardiovascular system, Extirpation. Computer Aided Mechanical Aspiration treats occlusions. The Indigo® System uses a mechanical pump (the Penumbra Engine®) to generate a vacuum for aspiration.
This field allows the entry of 1 character indicator and 12 diagnosis codes at a maximum of 7 characters in length.
Thrombosis might occur with Privigen, even in the absence of known risk factors. Patients could also experience hyperproteinemia, increased serum viscosity, or hyponatremia; infrequently, aseptic meningitis syndrome (AMS) may occur—more frequently with high doses (2 g/kg) and/or rapid infusion.
Privigen is indicated as replacement therapy for patients with primary immunodeficiency (PI) associated with defects in humoral immunity, including but not limited to common variable immunodeficiency (CVID), X-linked agammaglobulinemia, congenital agammaglobulinemia, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. Privigen is also indicated to raise platelet counts in patients with chronic immune thrombocytopenic purpura (ITP).
Pregnancy Category C. Animal reproduction studies have not been conducted with Privigen. It is not known whether Privigen can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Privigen should be given to pregnant women only if clearly needed. Immunoglobulins cross the placenta from maternal circulation increasingly after 30 weeks of gestation.16,17